To our knowledge, this is the largest published cohort of LA cases tested for EGFR mutation using DNA sequencing–based platforms in Brazil and the largest comprehensive analysis of driver mutations in lung cancer in our population. The gene discussed is EGFR; the disease is lung carcinoma.